Increased autophagy blocks HER2-mediated breast tumorigenesis
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Significance: Approximately 20% of breast cancers have amplification of a cancer-causing signaling molecule known as human epidermal growth factor receptor 2 (HER2). Decreased mRNA expression of the autophagy gene, beclin 1/BECN1 , increases the risk of HER2-positive breast cancer. However, the role of Beclin 1-dependent autophagy in regulating HER2-mediated tumorigenesis is unknown. Here, we show that a mutation in Becn1 that increases basal autophagy prevents HER2-mediated tumorigenesis in mice and prevents HER2-mediated inhibition of autophagy in cultured cells. Furthermore, treatment with a cell-penetrating, autophagy-inducing peptide derived from Beclin 1 inhibits growth of HER2-positive human breast tumor xenografts in mice as efficiently as a clinically used agent that inhibits HER2 receptor tyrosine kinase activity. These findings demonstrate that genetic and pharmacological activation of autophagy inhibits HER2-mediated breast tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of autophagy and inhibition of tumorigenesis by beclin 1
Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., & Levine, B. (1999) · Nature · doi:10.1038/45257 · Cited by 3,347 · cited 1×
“In mice, its allelic loss results in increased mammary tumorigenesis (8, 9), and its enforced expression reduces the growth of human breast cancer xenografts (10, 11).”
BackgroundSelf-citationPromotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene
Qu, X., Yu, J., Bhagat, G., Furuya, N., Hibshoosh, H., Troxel, A., Rosen, J., Eskelinen, E.-L., Mizushima, N., Ohsumi, Y., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20039 · Cited by 2,311 · cited 1×
“In mice, its allelic loss results in increased mammary tumorigenesis (8, 9), and its enforced expression reduces the growth of human breast cancer xenografts (10, 11).”
BackgroundSelf-citationSelf-consumption: the interplay of autophagy and apoptosis
Mariño, G., Niso-Santano, M., Baehrecke, E. H., & Kroemer, G. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3735 · Cited by 2,172 · cited 1×
“As it is well established that autophagy gene knockdown increases short-term susceptibility to apoptotic cell death (35), such findings do not directly address the role of autophagy in anti-HER2 treatment responses.”
BackgroundNagata, Y., Lan, K.-H., Zhou, X., Tan, M., Esteva, F. J., Sahin, A. A., Klos, K. S., Li, P., Monia, B. P., Nguyen, N. T., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.022 · Cited by 1,858 · cited 1×
“Moreover, clinical resistance to targeted HER2 therapies may occur as a result of mutations in signaling pathways downstream of the HER2 receptor that suppress autophagy, such as PI3K activating mutations or PTEN loss [which result in Akt and mechanistic target of rapamycin (mTOR) activation] (13, 14), and in preclini…”
BackgroundBerns, K., Horlings, H. M., Hennessy, B. T., Madiredjo, M., Hijmans, E. M., Beelen, K., Linn, S. C., Gonzalez-Angulo, A. M., Stemke-Hale, K., Hauptmann, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.030 · Cited by 1,627
Serra, V., Markman, B., Scaltriti, M., Eichhorn, P. J. A., Valero, V., Guzman, M., Botero, M. L., Llonch, E., Atzori, F., Di Cosimo, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1385 · Cited by 787 · cited 1×
“Moreover, clinical resistance to targeted HER2 therapies may occur as a result of mutations in signaling pathways downstream of the HER2 receptor that suppress autophagy, such as PI3K activating mutations or PTEN loss [which result in Akt and mechanistic target of rapamycin (mTOR) activation] (13, 14), and in preclini…”
BackgroundIdentification of a candidate therapeutic autophagy-inducing peptide
Shoji-Kawata, S., Sumpter, R., Leveno, M., Campbell, G. R., Zou, Z., Kinch, L., Wilkins, A. D., Sun, Q., Pallauf, K., MacDuff, D., et al. (2013) · Nature · doi:10.1038/nature11866 · Cited by 760
Self-citationAkt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation
Wang, R. C., Wei, Y., An, Z., Zou, Z., Xiao, G., Bhagat, G., White, M., Reichelt, J., & Levine, B. (2012) · Science · doi:10.1126/science.1225967 · Cited by 728 · cited 4×
“Moreover, we showed that Akt-mediated Beclin 1 phosphorylation and autophagy suppression contribute to the transforming and tumorigenic activity of Akt (18).”
BackgroundInfluentialSelf-citationFGF signalling regulates bone growth through autophagy
Cinque, L., Forrester, A., Bartolomeo, R., Svelto, M., Venditti, R., Montefusco, S., Polishchuk, E., Nusco, E., Rossi, A., Medina, D. L., et al. (2015) · Nature · doi:10.1038/nature16063 · Cited by 199 · cited 1×
“This peptide (or a version containing 18 amino acids of Beclin 1) (21) induces autophagy in vitro and in vivo in a manner that requires Beclin 1 and downstream autophagy machinery (21); is well-tolerated in vivo (21); and has been shown to have beneficial effects in rodent models of infection (21, 26), cardiac disease…”
BackgroundRocchi, A., Yamamoto, S., Ting, T., Fan, Y., Sadleir, K., Wang, Y., Zhang, W., Huang, S., Levine, B., Vassar, R., et al. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1006962 · Cited by 166 · cited 3×
“We recently reported that mice (Becn1) with a homozygous knock-in mutation that results in an F121A substitution in Beclin 1 have decreased interaction of Beclin 1 with Bcl-2 and increased autophagy in tissues such as skeletal muscle and brain (20).”
BackgroundMethodInfluentialSelf-citation
Cited by
Biological Functions of Autophagy Genes: A Disease Perspective
Levine, B., & Kroemer, G. (2019) · Cell · doi:10.1016/j.cell.2018.09.048 · Cited by 2,832
Self-citationGuidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897
Self-citationThe Roles of Autophagy in Cancer
Yun, C. W., & Lee, S. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113466 · Cited by 965
Autophagy and disease: unanswered questions
Yang, Y., & Klionsky, D. J. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0480-9 · Cited by 369
Comprehensive autophagy evaluation in cardiac disease models
Kaludercic, N., Maiuri, M. C., Kaushik, S., Fernández, Á. F., de Bruijn, J., Castoldi, F., Chen, Y., Ito, J., Mukai, R., Murakawa, T., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvz233 · Cited by 64
Self-citation
Metadata
- Authors
- Vega-Rubín-de-Celis, S., Zou, Z., Fernández, Á. F., Ci, B., Kim, M., Xiao, G., Xie, Y., & Levine, B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2018-04-02
- Volume
- 115
- Issue
- 16
- Pages
- 4176-4181
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2795546909
- Cited by
- 128
- References
- 10
- FWCI
- 12.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased autophagy blocks HER2-mediated breast tumorigenesis. https://app.cochat.ai/papers/10.1073/pnas.1717800115
- The paper
- Vega-Rubín-de-Celis, S., Zou, Z., Fernández, Á. F., Ci, B., Kim, M., Xiao, G., Xie, Y., & Levine, B. (2018). Increased autophagy blocks HER2-mediated breast tumorigenesis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1717800115
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.